Waycross Partners’s Boston Scientific BSX Stock Holding History

Waycross Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.6M	Buy	271,230 +3,584	+1%	+$195K	0.99%	29
2026 Q1	$16.8M	Buy	267,646 +242,646	+971%	+$19.4M	1.6%	27
2025 Q4	$2.38M	Buy	+25,000	New	+$2.45M	0.2%	48
2023 Q4	–	Sell	-19,900	Closed	-$1.05M	–	85
2023 Q3	$1.05M	Hold	19,900	–	–	0.23%	54
2023 Q2	$1.08M	Hold	19,900	–	–	0.23%	54
2023 Q1	$996K	Sell	19,900 -2,100	-10%	-$99K	0.29%	50
2022 Q4	$1.02M	Hold	22,000	–	–	0.37%	49
2022 Q3	$852K	Buy	+22,000	New	+$883K	0.57%	53

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Waycross Partners's BSX Position: Q2 2026 in Review

Waycross Partners increased its Boston Scientific (BSX) stake by 1.3% in Q2 2026, buying an estimated $195K and bringing the position to 271,230 shares worth $11.6M. The position accounts for 0.99% of the portfolio, ranked #29.

Waycross Partners first reported a position in BSX in Q3 2022 and has held it in 8 quarters since. The position peaked at $16.8M in Q1 2026. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Waycross Partners held 271,230 shares of Boston Scientific worth $11.6M as of Q2 2026.
Waycross Partners bought 3,584 Boston Scientific shares in Q2 2026, an estimated $195K.
Boston Scientific made up 0.99% of Waycross Partners's portfolio in Q2 2026, its #29 holding.
Waycross Partners first reported a position in Boston Scientific in Q3 2022 and has held it in 8 quarters since.
Waycross Partners's Boston Scientific position peaked at $16.8M in Q1 2026.
1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Waycross Partners's 13F filing for Q2 2026, filed 11 Aug 2026.